Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: INTEGRUM SCIENTIFIC LLC
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2021-09-17 to 2024-09-17
Current total value of award: $1401046.34
Description: DEVELOPMENT OF NOVEL MONOCLONAL ANTIBODIES AND LONGITUDINAL STUDY OF IMMUNE RESPONSES USING SERUM AND PERIPHERAL BLOOD MONONUCLEAR CELLS OF INFECTIOUS DISEASE SURVIVORS FOR USAMRIID